MAXgene® GMP Transfection Reagent, Powder (26435)


MAXgene® GMP is a high-performance, cGMP-grade transfection reagent engineered specifically for efficient plasmid DNA delivery in large-scale production.

Size: 1g - 26435-1
Contact Us for Pricing
MAXgene® GMP is a high-performance, cGMP-grade transfection reagent engineered specifically for efficient plasmid DNA delivery in large-scale production. Designed to support the manufacture of high-titer adeno-associated viral (AAV) and lentiviral (LV) vectors, as well as recombinant protein and monoclonal antibody (mAb) production. Trusted by researchers worldwide, MAXgene GMP is used in 1 in 5 clinical trials for cell and gene therapies, making it a leading choice for translational research and therapeutic development.

As part of the Kyfora PEI MAX® line, MAXgene® GMP combines the proven performance of our research-grade products with the scalability, validation, and regulatory compliance needed for a smooth transition from development to clinical trials up through commercialization. MAXgene GMP is fully synthetic and manufactured under cGMP 21 CFR 820 (ISO 13485) Quality Management System.
Store At Temperature 2 - 8°C
Shipping Condition Cold pack

Broad-Spectrum Transfection

  • Efficiently transfects a wide array of cell types, making it ideal for diverse applications in bioproduction.

High Transfection Efficiency

  • Optimized to deliver superior transfection rates with low cytotoxicity, maximizing viral vector, protein, and mAb titers.

1 in 5 Clinical Trials

  • Validated in 50+ cell and gene therapy clinical trials, affirming its reliability and effectiveness in therapeutic development.

Lot-to-Lot Consistency

  • Provides dependable, reproducible results across batches for consistent performance in clinical and commercial applications.

User-Friendly

  • Easily integrates into diverse workflows, adaptable from research to production environments.

Scalable

  • Suitable for use in well plates, flasks, and bioreactors, ensuring seamless scale-up from bench to large-scale biomanufacturing.

Cost Effective

  • Optimized for economic efficiency, offering substantial value compared to alternative transfection solutions.

Clinical and Commercial Ready

  • Specifically developed for viral vector production, recombinant protein, and mAb manufacturing at all stages of development.

Seamless Transition

  • Complements research-grade products for streamlined process development and scale-up.

You may also like

Recently viewed